RollingStone

214610KOSDAQHealth CareTrading haltedAdministrative issue
US$1.73
▲ +US$0.00 (+0.00%)Close · 2026-10-21
Share price
▼ −46.1%over 1y
25/1026/0126/0426/0726/10
$2.0$2.5$3.0

Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.

What the company does

RollingStone develops portable diagnostic devices and test kits that detect infectious diseases, blood conditions, and food-safety issues at or near the point of care, without sending samples to a central laboratory.

Its products serve hospitals, public-health programs, and agricultural or food-industry customers, and the company supplies export markets as well as the domestic Korean market. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company spans three diagnostic lines: molecular diagnostics, immunodiagnostics, and biochemical diagnostics, rather than relying on a single product category.

Summary is AI-generated and may contain errors · figures from DART filings

KEY FACTS
Market capUS$14.5M
SectorHealth Care
SubsectorMedical Devices
MarketKOSDAQ
Cap tierSmall-cap
Financials
6Y · FY2020~2025 · USD · all filed years
Revenue
US$8.2MFY2025 · latest
'20'22'25
low US$3.5Mhigh US$34.5M
Operating profit
−US$7.5MFY2025 · loss · latest
'20'22'25
low −US$19.5Mhigh US$2.6M
● red = loss year
Net income
−US$18.2MFY2025 · loss · latest
'20'22'25
low −US$29.4Mhigh −US$4.4M
● red = loss year
Hover or tap a year for its figure · red dot = loss year · latest FY2025
Why it matters · Context, not a recommendation

Its malaria molecular diagnostic kit holds the only approval from Korea's Ministry of Food and Drug Safety for that mosquito-borne disease indication, and it has registered its core technology as patents across multiple advanced economies.

Quick answers

RollingStone in five facts

What does RollingStone do?

RollingStone develops portable diagnostic devices and test kits that detect infectious diseases, blood conditions, and food-safety issues at or near the point of care, without sending samples to a central laboratory.

Where is RollingStone listed and in which sector?

RollingStone (Korean name: 롤링스톤) trades under KRX code 214610 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.

How large is RollingStone?

Its market capitalisation was US$14.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).

What were RollingStone's latest annual revenue and operating profit?

For fiscal year 2025, RollingStone reported revenue of US$8.2M, an operating loss of US$7.5M and a net loss of US$18.2M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 134.6% on the previous year.

Where does this data come from?

Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.

Data sources

Data sources and last updated

Filings and financial statements
DART (dart.fss.or.kr), Korea's official corporate-filing system
Prices, market cap, trading status
KRX (Korea Exchange), via FinanceDataReader
Latest annual financials
Fiscal year 2025, data retrieved from DART on 2026-10-02
Share price and market cap
Close of 2026-10-21
Currency
US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
Company data updated
2026-10-21
Company summary
AI-generated from filings; may contain errors. Information only, not investment advice.